Multiple Sclerosis News Today

January 15, 2021January 15, 2021

Sexual Dysfunction Common in Men with MS, Review Finds

Sexual dysfunction affects more than 60% of adult men with multiple sclerosis (MS), according to a review study. The data add to previous findings showing that more than two-thirds of ... Read more

January 14, 2021January 15, 2021

New Technique May Help Isolate, Characterize T-cells in MS Research

COVID-19 News, Multiple Sclerosis News Today

Scientists at the UCLA Broad Stem Cell Research Center have developed a technique able to more efficiently isolate specific T-cells — immune cells involved not only in the fight against ... Read more

January 14, 2021January 14, 2021

Public-private Partnership Will Assess Therapy Potential, Effects of CBD

Multiple Sclerosis News Today

Open Book Extracts (OBX) and Case Western Reserve University School of Medicine have partnered to investigate how cannabinoids like CBD affect brain cells, particularly in regard to neuroinflammation, according to ... Read more

January 13, 2021January 14, 2021

HTR2A Gene Changes Found Only in Progressive MS May Be New Biomarker

Multiple Sclerosis News Today

Scientists have discovered epigenetic changes in a gene called HTR2A, found only in immune cells isolated from people with secondary progressive multiple sclerosis (SPMS), a study reported. These findings suggest ... Read more

January 13, 2021January 13, 2021

GW Pharma Plans More Clinical Trials for Sativex

Multiple Sclerosis News Today

GW Pharmaceuticals is planning to continue recruiting patients into two pivotal Phase 3 clinical trials of Sativex (nabiximols), an oral spray that contains cannabis extracts and is being investigated as a ... Read more

January 12, 2021January 12, 2021

Lemtrada May Slow MS Disease Progression, Long-term Study Suggests

Multiple Sclerosis News Today

Lemtrada (alemtuzumab) may slow the progression of multiple sclerosis (MS) and lower the conversion rate of relapsing-remitting MS (RRMS) to secondary progressive MS (SPMS), a long-term study suggests. The results showed ... Read more

January 12, 2021January 12, 2021

Helius Provides More Information to FDA About PoNS Device

Multiple Sclerosis News Today

Helius Medical Technologies has submitted its response to the U.S. Food and Drug Administration (FDA)’s request for more information about the company’s application for de novo classification and clearance of its ... Read more

January 11, 2021January 12, 2021

Cancer Therapy Seen to Protect Blood-brain Barrier, Ease MS in Mouse Model

Multiple Sclerosis News Today

Imatinib, a cancer treatment, stopped an injury response mechanism of the central nervous system (CNS) from activating, damage to which is a hallmark of multiple sclerosis (MS), an early study ... Read more

January 11, 2021January 11, 2021

BioNTech Vaccine Treats MS in Mice Without Dampening Immune System

COVID-19 News, Multiple Sclerosis News Today

BioNTech’s experimental non-inflammatory vaccine — designed to dampen the abnormal immune responses seen in multiple sclerosis (MS) against myelin — delayed the onset and lessened the severity of symptoms in ... Read more

January 8, 2021January 9, 2021

Study: Past Long-term DMT Use Tapers Risk of Current MS Progression

Multiple Sclerosis News Today

Long-term use of disease-modifying therapies (DMTs) in people with relapsing-remitting multiple sclerosis (RRMS) has a beneficial cumulative effect compared to shorter treatments, delaying the development of irreversible disability and conversion ... Read more

January 8, 2021January 9, 2021

Target Tissues of Immune Attacks Too Often Ignored in Research, Study Says

Multiple Sclerosis News Today

To fully understand autoimmune diseases like multiple sclerosis (MS), it is necessary to study not just the immune system, but also the tissue that the immune system is attacking, a ... Read more

January 7, 2021January 8, 2021

CXCL13, Inflammatory Marker, May Be Good at Predicting Likely MS Activity

Multiple Sclerosis News Today

CXCL13, an inflammatory biomarker, may be a good marker of likely future disease activity in people with multiple sclerosis (MS), a study suggests. The study, “Intrathecally produced CXCL13: A predictive biomarker ... Read more

January 7, 2021January 7, 2021

Obesity, High BMI Linked to Greater MS Risk, Autoimmune Activity

Multiple Sclerosis News Today

Obesity and a higher body mass index (BMI) are associated with both increased multiple sclerosis (MS) risk and harmful autoimmune activity that is induced by leptin, a hormone secreted by ... Read more

January 6, 2021January 7, 2021

Less Sunlight Means More Risk of Relapse, Disability, Studies Assert

Multiple Sclerosis News Today

Reduced exposure to sunlight, previously reported as a risk factor for developing multiple sclerosis (MS), also seems to increase the risk for relapse and worsening disability, data from two clinical ... Read more

January 6, 2021January 6, 2021

MSAA Hosting 8th Webinar on COVID-19 and MS

COVID-19 News, Multiple Sclerosis News Today

The Multiple Sclerosis Association of America (MSAA) is hosting a webinar in which experts will discuss the COVID-19 pandemic and its impact on multiple sclerosis (MS). The webinar, “What You ... Read more